- 4.6Impact Factor
- 8.6CiteScore
- 16 daysTime to First Decision
Aptamers: Successes, Limitations and Future Directions
This special issue belongs to the section “Chemical Biology“.
Special Issue Information
Dear Colleagues,
Aptamers, generated by the systematic evolution of ligands by exponential enrichment (SELEX) process, are short, artificial, single-stranded oligonucleotides that, similarly to antibodies, interact at high affinity with their targets by recognizing a specific three-dimensional structure. They offer suitable features for analytical, diagnostic, and therapeutic applications, including easy manufacturing and great reproducibility from batch-to-batch, structural stability, and low/absent immunogenicity. Because of their nucleic acid nature, the rational design of advanced strategies to manipulate aptamers for wide-ranging applications is greatly simplified over antibodies.
This Special Issue will include original research articles and review articles on all aspects of aptamer research, including aptamer selection technology, engineering/modification strategies, analytical applications, imaging modalities, nanotechnology, diagnostics, and therapeutics. It aims to attract contributions highlighting problems, solutions, and future directions in the development of aptamers as molecular recognition elements from basic research toward diverse commercial applications.
Dr. Laura Cerchia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Aptamers
- Aptamer diagnostics
- Aptamer therapeutics
- Aptamer imaging
- Aptamer sensors
- Aptamer nanotechnology
- Aptamer nanomedicine
- Targeted delivery systems
- SELEX
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

